Brainlab is a pioneer in digital medical technology, operating in the healthcare sector. The company's main offerings include software-driven medical solutions that digitize, automate, and optimize clinical workflows for various surgical procedures and radiotherapy. These solutions primarily cater to physicians, medical professionals, and their patients. It was founded in 1989 and is based in Munich, Germany.
Expert Collections containing Brainlab
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Brainlab is included in 2 Expert Collections, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Brainlab has filed 596 patents.
Satellite navigation systems, Surgery, Medical imaging, Navigation, Global Positioning System
Satellite navigation systems, Surgery, Medical imaging, Navigation, Global Positioning System
Latest Brainlab News
Nov 6, 2023
| Apollo Hospitals Enterprise Ltd., B.Braun SE, Brainlab AG, and more among the key companies in the market - Technavio News provided by Share this article Share toX NEW YORK, Nov. 6, 2023 /PRNewswire/ -- The Neuronavigation Systems Market size is expected to grow by USD 227.65 million, accelerating at a CAGR of 7.06% during the forecast period, according to Technavio Research. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report Technavio has announced its latest market research report titled Global Neuronavigation Systems Market Market 2024-2028 The report also offers detailed analyses of the market's competitive landscape, featuring information on leading companies including Apollo Hospitals Enterprise Ltd., B.Braun SE, Brainlab AG, Clearpoint Neuro Inc., Fiagon GmbH, Heal Force Biomeditech Holdings Ltd., inTRAvent Medical Partners, KARL STORZ SE and Co. KG, Lexmark International Inc., Medtronic Plc, Nexstim Plc, Orthofix Medical Inc., Parsiss Co., Roper Technologies Inc., Soterix Medical Inc., Stryker Corp., Synaptive Medical Inc., The Magstim Co. Ltd., Xoran Technologies LLC and Zimmer Biomet Holdings Inc. Neuronavigation Systems Market 2024 – 2028: Company Profile: Heal Force Biomeditech Holdings Ltd.: The company offers neuro navigation systems such as Accurate Navigation for Glioma Resection which provides surgical treatment of brain functional gliomas. • To gain access to more company profiles available with Technavio, buy the report Neuronavigation Systems Market 2024 – 2028: Segmentation Analysis The market is segmented by Product (Optical and Electromagnetic), End-user (Hospitals, ASCs, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)). The optical segment is expected to experience substantial market share growth during the forecast period. Optical neuronavigation systems utilize a combination of stereoscopic optical cameras, infrared emitters (IR), and reflective markers. These systems employ three-dimensional (3D) positioning technology, which involves monitoring a specific measurement area through two or more cameras equipped with infrared filters placed in front of their lenses. The majority of neuronavigation systems in the neuro-navigation systems market currently rely on optical tracking technology. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report Neuronavigation Systems Market 2024 – 2028: Regional Analysis North America is expected to play a significant role in driving global market growth, contributing approximately 47%. This is primarily due to factors like technological advancements, the introduction of new products, and increased investment in innovative medical devices, which are anticipated to fuel the expansion of the neuronavigation systems market in North America. Neuronavigation Systems Market 2024 – 2028: Driver & Trend: Driver Market growth is primarily driven by the rising prevalence of chronic neurological disorders, largely attributed to the expanding geriatric population and increased life expectancy. The elderly population's growth significantly elevates the risk of neurological diseases, further fueling market expansion. Essential tremor (ET) affects about 4 in every 100 individuals worldwide, with its incidence notably increasing with age. This surge in neurological disorders is spurring demand for minimally invasive surgeries. The increased demand for neuronavigation systems is, in turn, driving growth in the global neuronavigation systems market during the forecast period. Trend - The emergence of hybrid operating rooms with integrated healthcare infrastructure is the primary trend in the market. Related Reports: Neurofeedback Systems Market : The neurofeedback systems market share is expected to increase by USD 514.64 million from 2021 to 2026. Neurovascular Devices Market: The neurovascular devices market share is expected to increase by USD 955.15 million from 2021 to 2026. What are the key data covered in this neuronavigation systems market report? CAGR of the market during the forecast period Detailed information on factors that will drive the growth of the neuronavigation systems market between 2024 and 2028. Precise estimation of the neuronavigation systems market size and its contribution to the market in focus on the parent market A thorough analysis of the market's competitive landscape and detailed information about vendors TOC: About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts
Brainlab Frequently Asked Questions (FAQ)
When was Brainlab founded?
Brainlab was founded in 1989.
Where is Brainlab's headquarters?
Brainlab's headquarters is located at Olof-Palme-Straße 9, Munich.
What is Brainlab's latest funding round?
Brainlab's latest funding round is Private Equity.
Who are the investors of Brainlab?
Investors of Brainlab include EMH Partners and Intel Capital.
Who are Brainlab's competitors?
Competitors of Brainlab include apoQlar, ImmersiveTouch, MindTrace, OneMedNet, Life Image and 7 more.
Compare Brainlab to Competitors
MediView provides a surgical navigation system. It offers surgeons advanced visualization for augmented reality, remote connectivity, and spatial computing data to create surgical navigation. MediView was founded in 2017 and is based in Cleveland, Ohio.
OneMedNet is a company focused on the healthcare and life sciences sectors. It provides research and regulatory-ready, image-centric data to life science innovators, curating and presenting data regardless of its complexity, specificity, or diversity. The company primarily serves the life sciences industry. It was founded in 2006 and is based in Eden Prairie, Minnesota.
Omniscient Neurotechnology is a data company that operates in the healthcare and technology sectors, with a focus on brain-related disorders. The company offers solutions that process and analyze complex brain network data, known as connectomics, to provide actionable insights for neurosurgeons and researchers. These insights are used to enhance patient care and facilitate research in the field of neurology. It was founded in 2019 and is based in Sydney, New South Wales.
Stryker (NYSE: SYK) develops, manufactures, and markets specialty surgical and medical products worldwide. It offers orthopedic implants, trauma systems, powered surgical instruments, endoscopic systems, and, patient care and handling equipment. It was founded in 1941 and is based in Kalamazoo, Michigan.
Medivis offers a surgical augmented reality (AR) technology platform for surgical applications. It offers solutions such as cranial navigation, spine navigation, body navigation among others. The company was founded in 2016 and is based in New York, New York.
Medicom Technologies is a company focused on healthcare interoperability within the healthcare industry. The company offers a range of services including the secure and seamless exchange of health information, facilitating the quick location of patient records, and the de-identification of data for research purposes. Medicom Technologies primarily serves the healthcare, government, and life sciences sectors. It was founded in 2015 and is based in Raleigh, North Carolina.